Small CDMO

Syngene International Ltd.

SYNGENE

Market Cap
₹16,928 Cr.
P/E
53.45

Syngene International Ltd.

  • Syngene Internatl.
  • Piramal Pharma
  • Laurus Labs
  • TJI Pharma - API & CRAMS

FAQs on Syngene International Ltd. Shareprice

Syngene Internatl. has given lower returns compared to its competitors.
Syngene Internatl. has grown at ~-18.64% over the last 3yrs while peers have grown at a median rate of 7.91%

Syngene Internatl. is not expensive.
Latest PE of Syngene Internatl. is 53.45, while 3 year average PE is 58.3.
Also latest EV/EBITDA of Syngene Internatl. is 17.53 while 3yr average is 28.18.

View FAQ's On Business

Growth Table

  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Balance Sheet

  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Cash Flow

  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Quarterly Results

  • Syngene International Ltd.
  • Piramal Pharma
  • Laurus Labs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Syngene International Ltd. Financials

Balance sheet of Syngene Internatl. is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Syngene Internatl. is decreasing.
Latest net debt of Syngene Internatl. is -₹1,656.6 Crs as of Mar-26.
This is less than Mar-25 when it was -₹1,454.2 Crs.

No, profit is decreasing.
The profit of Syngene Internatl. is ₹317 Crs for Mar 2026, ₹496 Crs for Mar 2025 and ₹510 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Syngene Internatl. latest dividend payout ratio is 15.9% and 3yr average dividend payout ratio is 11.96%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech